UMIN ID: UMIN000001504
Registered date:13/11/2008
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | resectable pancreatic cancer |
| Date of first enrollment | 2008/11/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Neoadjuvant treatment with gemcitabine and S1 |
Outcome(s)
| Primary Outcome | 2 year survival rate |
|---|---|
| Secondary Outcome | Adverse effect, resectability rate, pathological effect, recurrence free survival, patterns of recurrence, reduction rate and normalization rate for tumor marker |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) pulmonary fibrosis or interstitial pneumonitis 2) tumor other than ductal carcinoma 3) distant metastasis 4) R2 resection 5) prior anti-cnacer therapy 6) pregnancy 7) under 18 years old |
Related Information
| Primary Sponsor | Department of surgery, Tohoku University |
|---|---|
| Secondary Sponsor | Miyagi HBP COG |
| Source(s) of Monetary Support | None (Self-funding) |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Motoi Fuyuhiko |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan Japan |
| Telephone | 022-717-7205 |
| fmotoi@surg1.med.tohoku.ac.jp | |
| Affiliation | Tohoku University Hospital Hepato-Biliary Pancreatic surgery |
| scientific contact | |
| Name | Michiaki Unno |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan Japan |
| Telephone | 022-717-7205 |
| Affiliation | Tohoku University Hospital Hepato-Biliary Pancreatic surgery |